Background Asthma is a heterogeneous disease in which there is a differential response to
asthma treatments. This heterogeneity needs to be evaluated so that a personalized …

This document provides recommendations for monitoring and treatment of children in whom
bronchopulmonary dysplasia (BPD) has been established and who have been discharged …

Objective To demonstrate and validate the improvement of current risk stratification for
bronchopulmonary dysplasia (BPD) early after birth by plasma protein markers (sialic acid-…

Background Gemcitabine (dFdC) is an active antitumour agent with radiosensitising properties,
shown both in preclinical and clinical studies. In the present study, the relation between …

Parents and individuals who were born preterm rarely contribute to research study design in
order to ensure that outcomes are reported that are of relevance to them. In this article we …

Introduction Other than for agreement that own mother's milk is the optimum feed, nutritional
practice for very preterm babies varies widely. As part of the development of a randomised …

… My parents Han and Anjo Kamphuis have always believed in me unconditionally and have
encouraged me to follow my own path. My brother Arjen Kamphuis is always there to offer …

U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical
companies and six patient organisations with the objective of improving the understanding …

U-BIOPRED aims to characterise paediatric and adult severe asthma using conventional
and innovative systems biology approaches. A total of 99 school-age children with severe …

Background Growing evidence indicates high comorbid anxiety and depression in patients
with asthma. However, the mechanisms underlying this comorbid condition remain unclear. …